Intraocular pressure after intravitreal injection of triamcinolone acetonide. - Wikidata - awgldk - TriplyDB

Intraocular pressure after intravitreal injection of triamcinolone acetonide.

Intraocular pressure after intravitreal injection of triamcinolone acetonide.

http://www.wikidata.org/entity/Q35590421

about

Emerging drugs for uveitis The combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabeticfoveal oedema and cataract.Moving Past Anti-VEGF: Novel Therapies for Treating Diabetic Retinopathy Emerging therapies for neovascular age-related macular degeneration: state of the art Intraocular pressure rise is predictive of vision improvement after intravitreal triamcinolone acetonide for diabetic macular oedema: a retrospective analysis of data from a randomised controlled trial.Clinical trials on corticosteroids for diabetic macular edema Diffuse diabetic macular oedema treated by intravitreal triamcinolone acetonide: a comparative, non-randomised study.Cataract surgery after intravitreal injection of triamcinolone acetonide.Future pharmacological treatment options for nonexudative and exudative age-related macular degeneration.Intravitreal triamcinolone for diffuse diabetic macular oedema.Intravitreal cortisone injection for refractory diffuse diabetic macular edema.Laser photocoagulation combined with intravitreal triamcinolone acetonide injection in proliferative diabetic retinopathy with macular edema.Posterior subtenon triamcinolone, intravitreal triamcinolone and grid laser photocoagulation for the treatment of macular edema in branch retinal vein occlusion.A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema.Intravitreal bevacizumab for treatment of diabetic macular edema Experimental investigation of needles, syringes and techniques for intravitreal injections.Comparison of the effects of intravitreal bevacizumab and triamcinolone acetonide in the treatment of macular edema secondary to central retinal vein occlusion Comparison of intravitreal triamcinolone treatment and intravitreal triamcinolone with grid laser treatment in patients with diffuse diabetic macular edema.Triamcinolone-induced intraocular pressure elevation: intravitreal injection for macular edema and posterior subtenon injection for uveitis Intravitreal triamcinolone reinjection for refractory diabetic macular edema.Combination therapy for diabetic macular edema.Glucocorticoid induction of occludin expression and endothelial barrier requires transcription factor p54 NONO Steroid differentiation: the safety profile of various steroids on retinal cells in vitro and their implications for clinical use (an American Ophthalmological Society thesis).Treatment of diabetic macular edema with sustained-release glucocorticoids: intravitreal triamcinolone acetonide, dexamethasone implant, and fluocinolone acetonide implant.Estimation of ocular volume from axial length.Intravitreal triamcinolone acetonide for exudative age related macular degeneration.Factors influencing visual acuity after intravitreal triamcinolone acetonide as treatment of exudative age related macular degeneration.Intraocular pressure alterations following intravitreal triamcinolone acetonide.Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.Photographic estimation of the duration of high dose intravitreal triamcinolone in the vitrectomised eye Intravitreal triamcinolone for acute branch retinal vein occlusion: a randomized clinical trial.The combination of phacoemulsification surgery and intravitreal triamcinolone injection in patients with cataract and diabetic macular edema Elevated Intraocular Pressure After Intravitreal Steroid Injection in Diabetic Macular Edema: Monitoring and Management.Immunological factors in the pathogenesis and treatment of age-related macular degeneration.National survey of the technique of intravitreal triamcinolone injection in the United Kingdom.The pros and cons of intravitreal triamcinolone injections for uveitis and inflammatory cystoid macular edema.Ocular morbidity associated with intravitreal triamcinolone acetonide.Intravitreal triamcinolone acetonide: a change in a paradigm.Posterior subtenon triamcinolone acetonide in gas-filled eyes as an adjunctive treatment for complicated proliferative diabetic retinopathy.Outcome of intravitreal triamcinolone acetonide in postoperative cystoid macular oedema.

P2860

Q24630848-74C77EE0-92A8-4717-9BD5-F352000FB271 Q24810825-2D758CB7-C6AD-4142-A2A4-A7FAD2F2611C Q28078199-E44769AB-F5C4-4AD1-B281-DF3062A80EB2 Q28253918-0E219CCD-D342-4D8D-8DB7-3683796DBC7E Q30863562-37B42A88-BBE3-4CC5-9769-2A969B52AF74 Q31146864-FDA2D00A-472F-4417-9A3B-DAB1743D7485 Q31148660-73A53633-A497-485E-B299-3ACB397C47D0 Q33201157-E941D161-5011-4EF3-9C59-DA4B552E9847 Q33212693-58659338-6A43-4528-9519-3A4E6EB35DC6 Q33219578-AFDB3144-710D-4EFB-965B-57FA38A51830 Q33227150-EEF74064-1535-40BA-A9A0-84752DCC0B9F Q33282848-927EDECE-FE7C-46C7-91B6-3B54CA774174 Q33306357-CFD25359-A671-4983-8BE7-E503567C6FBC Q33355710-E3E333B3-C1A8-404B-A58A-2125B929F69E Q33425236-E9A0F071-A986-4AB1-8EE0-AACB25EADE96 Q33727213-76F40AD4-EE12-4159-B899-336A9627E6AF Q33771437-FB068D23-13CF-405C-A876-16E80348DFA1 Q33973609-2C28DF34-6CB4-47B5-813C-8BC39EDB9757 Q34014954-7CB36083-60E2-401F-B470-619F29D42A57 Q34014971-1B4BCA95-49B6-4E00-AF29-D66A2CCE2C92 Q34241921-1D5E7D01-2E40-48AB-9BCF-157E1F908D09 Q34703697-22813461-4EB4-422F-B052-6F4AE7694E29 Q35030923-30102270-F234-4EE3-8ED7-96E898CD6B59 Q35128723-8F2D9A29-6B5B-4008-A088-55F040043993 Q35199647-3363C684-C3CF-470B-911B-6ECC27324983 Q35590749-8A43F4C1-176F-4AA4-876E-F17777381CB1 Q35592674-6E69B789-716A-43E9-B2B2-1D3AD8BF56BC Q35762005-B99AF8FD-6905-4F2F-A558-C11115F96603 Q35763017-7F331251-E969-464E-8E56-14BC36427E48 Q35769376-51908D85-D2A2-4BB3-AE83-444D51521C37 Q35835522-0B7F3CF0-FD7E-4E02-9F8C-53E3CBF718FE Q35947430-E3782626-AD64-4A80-B4DC-AAFF37C067FD Q36013578-7EDD0C63-F94A-49C5-80E0-DB6A5011112E Q36086191-7C0E34AE-0719-420D-AF3C-9B30BED23032 Q36378901-E0D77A8B-F0AA-466F-ADC2-51507666105B Q36441711-55C4C54F-FDBA-4823-8A34-715C736048F6 Q36482537-B87AD5C0-D7E8-4D6F-8A52-917B62B75DF7 Q36500994-443ED6AF-462B-429F-AAB1-36EF13A3B255 Q36549150-53E80462-872C-4626-92B6-13C5BAC6E684 Q36611020-912ECAAA-1A38-4CFA-AFF8-49366CEC1B93

P2860

Intraocular pressure after intravitreal injection of triamcinolone acetonide.

http://www.wikidata.org/entity/Q35590421

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Intraocular pressure after intravitreal injection of triamcinolone acetonide.

@ast

Intraocular pressure after intravitreal injection of triamcinolone acetonide.

@en

type

label

Intraocular pressure after intravitreal injection of triamcinolone acetonide.

@ast

Intraocular pressure after intravitreal injection of triamcinolone acetonide.

@en

prefLabel

Intraocular pressure after intravitreal injection of triamcinolone acetonide.

@ast

Intraocular pressure after intravitreal injection of triamcinolone acetonide.

@en

P1433

Q35590421-17D43ED7-2FF1-4E6A-B630-5414903ABE2E

P1476

Q35590421-829F42A4-A087-4A96-A778-AC1D3AA4F6F1

P2093

Q35590421-8EAEB143-8EA3-4691-91EC-3F6F04B2432D

Q35590421-A7F48BB4-9E9E-4574-9C67-B0B38C5F9CF9

Q35590421-EA129547-32DA-4B3C-9387-4E2918FB540B

P2860

Q35590421-038A2022-39A5-4A43-9906-736B4FAFCE8B

Q35590421-104A5614-F850-4973-A4FA-AE88A00BDE55

Q35590421-1F7AD2E9-0E97-4707-8347-81282ABB9D45

Q35590421-2997A813-379A-4CD1-A8FD-3A53C9ACC919

Q35590421-2B5CF35A-D005-4AFC-A686-459382D1A664

Q35590421-334A7BEB-84FE-4B9C-BF34-3DBDD036BC70

Q35590421-36AA72CD-E381-4870-817A-2D9FD9973FF4

Q35590421-5662B469-ADF2-45C2-8E9C-0DCA4A8F231F

Q35590421-72E38B38-8F18-4599-8806-95D47BDFD887

Q35590421-83AD90B5-2974-4171-A2AC-A9909AD9AF38

P304

Q35590421-B0CA3955-A04E-4BD0-BF1E-A3C843985EBF

P31

Q35590421-4B07BE0D-50CC-4975-A9CA-066DEEAE0367

P356

Q35590421-927C8AA1-0A86-4E34-9DC5-F7BCEFAE9618

P407

Q35590421-8676FFF9-9C1F-457A-8FA2-9A00E71394F6

P433

Q35590421-582C3632-745A-4E5B-9802-AF0DBCAD3372

P478

Q35590421-01046A11-B9CB-4D6D-A21E-C28D4BFFF2F4

P577

Q35590421-F609364E-7A8A-4A7D-BEC0-3AD7070F6170

P5875

Q35590421-8A0EE4AF-53DC-4F3E-9CD7-2B41FDEEA180

P698

Q35590421-096870C6-111F-4893-B6E1-A7854E0018F7

P932

Q35590421-D8333D6D-CD31-4BB5-9329-F6E56CE54CBF

P356

P1433

British Journal of Ophthalmology

P1476

Intraocular pressure after intravitreal injection of triamcinolone acetonide.

@en

P2093

I Kreissig

http://www.w3.org/2001/XMLSchema#string

J B Jonas

http://www.w3.org/2001/XMLSchema#string

R Degenring

http://www.w3.org/2001/XMLSchema#string

P2860

Triamcinolone acetonide modulates permeability and intercellular adhesion molecule-1 (ICAM-1) expression of the ECV304 cell line: implications for macular degeneration

Intravitreal triamcinolone acetonide inhibits choroidal neovascularization in a laser-treated rat model.

Intravitreal triamcinolone in subfoveal recurrence of choroidal neovascularisation after laser treatment in macular degeneration.

Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema.

Exudative macular degeneration and intravitreal triamcinolone. A pilot study.

Intravitreal triamcinolone for refractory diabetic macular edema.

The effect of an angiostatic steroid on neovascularization in a rat model of retinopathy of prematurity.

Retinal toxicity of triamcinolone acetonide in silicone-filled eyes.

Exudative macular degeneration and intravitreal triamcinolone: 18 month follow up.

Ophthalmoscopic evaluation of the optic nerve head.

P304

24-27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/BJO.87.1.24

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P577

2003-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273581244

http://www.w3.org/2001/XMLSchema#string

P698

12488256

http://www.w3.org/2001/XMLSchema#string

P932

1771462

http://www.w3.org/2001/XMLSchema#string